Carterra's Series B - II Round

Carterra raised a round of funding on September 14, 2018. Investors include Telegraph Hill Partners.

Carterra, fka Wasatch Microfluidics, is advancing LSA, a fully automated, high-throughput monoclonal antibody (mAb) characterization platform which enables label-free binding experiments to be perform…

Articles about Carterra's Series B - II Round: